Caregiver and Patient Support
Lymphoma Research Foundation (LRF) provides educational webcast and podcast programs for lymphoma patients, survivors and their loved ones on specific types of lymphoma, treatment options and patient support topics. Each webcast/podcast is presented by a leading healthcare professional. Webcast programs offer you the opportunity to navigate through a synchronized audio and slide presentation. Podcast (MP3) programs are presented in audio format only.
http://www.lymphoma.org
Consider listening to these webcasts:
Caregivers Program
Jeff Kane, MD (2004)
View Webcast
Everyday Eating with Cancer Fighting Superfoods
Kimberly Mathai, MS, RD (2006)
View Webcast | Download MP3
Finding and Interpreting Cancer Information
Carolyn Messner, DSW, LMSW (2008)
View Webcast
Going the Distance: Living with Lymphoma and Treatment Part I
Anne Coulthart, RN, CONC (2006)
View Webcast | Download MP3
Going the Distance: Living with Lymphoma and Treatment Part II
Cheryl Howe, RN, BN, CONC (2006)
View Webcast | Download MP3
Help Yourself: Targeted Strategies for Living Better with Lymphoma
Brian Stabler, PhD (2004)
View Webcast
Living Well With Lymphoma
Brian Stabler, PhD (2008)
View Webcast
Lymphoma Survivorship
Sandra Horning, MD (2008)
View Webcast
Lymphoma Survivorship
Christine Liebertz, NP, RN (2007)
View Webcast | Download MP3
Managing Short- and Long-term Side Effects
Christine Liebertz, NP, RN (2008)
View Webcast
More Articles
More Articles
Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...
The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...
Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...
At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...
Site Beginnings
This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...
Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...
The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...
The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...
The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...
According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...
Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...
New research suggests that frontline radioimmunotherapy...
Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...
